Diseases of the Nervous System | Hypertension, Phase II
Regulating Blood Pressure During Recovery from Intracerebral Hemorrhage (REDUCE)
Volunteers
Health Professionals
What is the purpose of this trial?
This study is looking to compare the effect of spironolactone-containing antihypertensive medications versus standard antihypertensive medications on home blood pressure in intracerebral hemorrhage (ICH) survivors.
- Trial withAmerican Heart Association
- Ages18 years and older
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Adam de Havenon, MD, MSCI
- Adam Jasne, MD
- Ahmed Elmashad
- Amit Mehta
- Barbara Gordon-Kundu, MD
- Caitlin Loomis, MD
- Guido Falcone, MD, ScD, MPH
- Hardik P Amin, MD
- Jaehan Park
- James A. Giles, MD, PhD, MPHS, MRCP
- Jorge Rodriguez
- Joseph Schindler, MD
- Lauren Hachmann Sansing, MD, MS, FAHA, FANA
- Mark Warman
- Melissa Mariscal, MD
- N. Abimbola Sunmonu, MD/PhD
- Nils Petersen, MD/PhD, MSc
- Nishant K. Mishra, MBBS, PhD, MD, FAHA
- Rachel Forman, MD
- Reshma Narula, MD
- Richa Sharma, MD, MPH
- Ruth Arnold
- Stefanie Cappucci
- Syed Ali
- Last Updated07/03/2023
- Study HIC#2000029811